These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20859891)

  • 21. Statins and risk of new-onset diabetes mellitus.
    Shah RV; Goldfine AB
    Circulation; 2012 Oct; 126(18):e282-4. PubMed ID: 23109518
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of cholesterol reducing therapy with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on secondary prevention after myocardial infarction in Japanese patients].
    Tachibana E; Watanabe I; Nagao K; Kanmatsuse K
    J Cardiol; 2000 Apr; 35(4):277-85. PubMed ID: 10791271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alteration in risk factor accumulations of acute myocardial infarction during the last one decade: analysis of patients admitted in Coronary Care Unit.
    Sasaki M; Saito T; Kubo N; Saito T; Ikoma A; Tamemoto H; Saito M; Kawakami M; Ishikawa SE
    Diabetes Res Clin Pract; 2006 Mar; 71(3):339-44. PubMed ID: 16182403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of serum cholesterol and cholesterol subfractions on restenosis following successful coronary intervention.
    Violaris AG; Ismail TF; El-Gendi H; Foale RA
    Semin Interv Cardiol; 1999 Sep; 4(3):111-9. PubMed ID: 10545617
    [No Abstract]   [Full Text] [Related]  

  • 25. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
    Schramm TK; Gislason GH; Køber L; Rasmussen S; Rasmussen JN; Abildstrøm SZ; Hansen ML; Folke F; Buch P; Madsen M; Vaag A; Torp-Pedersen C
    Circulation; 2008 Apr; 117(15):1945-54. PubMed ID: 18378618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholesterol levels.
    Woods AD
    Nursing; 2010 Aug; 40(8):31. PubMed ID: 20647877
    [No Abstract]   [Full Text] [Related]  

  • 27. Lipid Management Steps Forward.
    Siegel JA
    J S C Med Assoc; 2015 Dec-2016 Jan; 111(4):122-5. PubMed ID: 27141703
    [No Abstract]   [Full Text] [Related]  

  • 28. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
    Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C;
    Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study.
    Buyken AE; von Eckardstein A; Schulte H; Cullen P; Assmann G
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):230-6. PubMed ID: 17446801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypercholesterolemia in children.
    Shamir R; Lerner A; Fisher EA
    Isr Med Assoc J; 2000 Oct; 2(10):767-71. PubMed ID: 11344730
    [No Abstract]   [Full Text] [Related]  

  • 31. [The 10-minute consultation: accidently discovered hypercholesteremia].
    Tatò F
    MMW Fortschr Med; 2004 Sep; 146(35-36):59-60. PubMed ID: 15540545
    [No Abstract]   [Full Text] [Related]  

  • 32. Renal transplant dysfunction--importance quantified in comparison with traditional risk factors for cardiovascular disease and mortality.
    Soveri I; Holdaas H; Jardine A; Gimpelewicz C; Staffler B; Fellström B
    Nephrol Dial Transplant; 2006 Aug; 21(8):2282-9. PubMed ID: 16574686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Sugar does, indeed, harm!].
    Ochała A
    Kardiol Pol; 2010 Jul; 68(7):752. PubMed ID: 20648429
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevalence, treatment, and control of combined hypertension and hypercholesterolemia in the United States.
    Wong ND; Lopez V; Tang S; Williams GR
    Am J Cardiol; 2006 Jul; 98(2):204-8. PubMed ID: 16828593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peroxisome proliferator-activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease.
    Tenenbaum A; Motro M; Fisman EZ; Schwammenthal E; Adler Y; Goldenberg I; Leor J; Boyko V; Mandelzweig L; Behar S
    Circulation; 2004 May; 109(18):2197-202. PubMed ID: 15123532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term effects of simvastatin in hypercholesterolemic patients with NIDDM and additional atherosclerotic risk factors. Hyogo Simvastatin Study Group.
    Kazumi T; Yoshino G; Ohki A; Matsuba K; Ino T; Amano M; Kasuga M
    Horm Metab Res; 1995 May; 27(5):239-43. PubMed ID: 7642176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular disease in type 2 diabetics: epidemiology, risk factors and therapeutic modalities.
    Khamaisi M; Wexler ID; Skrha J; Strojek K; Raz I; Milicevic Z
    Isr Med Assoc J; 2003 Nov; 5(11):801-6. PubMed ID: 14650106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular Corner-Stable Coronary Artery Disease, An LDL "Vaccine," and Anti-inflammatories.
    Abbasi J
    JAMA; 2020 Apr; 323(13):1233-1234. PubMed ID: 32186687
    [No Abstract]   [Full Text] [Related]  

  • 40. [Differentiated treatment of diabetics with an acute coronary syndrome].
    Hamm CW; Hamann A
    Dtsch Med Wochenschr; 2006 Nov; 131(47 Suppl 7):S208-10. PubMed ID: 17109250
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.